Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Trevor Robbins

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Biological Psychiatry|October 4, 2002
Preclinical models: status of basic research in depressionEric J Nestler, Elizabeth Gould, Husseini Manji, et al.
Biological Psychiatry|May 10, 2008
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia InitiativeCameron S Carter, Deanna M Barch, Robert W Buchanan, et al.
Schizophrenia Bulletin|November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meetingDeanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Trials|August 11, 2023
Potential cognitive and neural benefits of a computerised cognitive training programme based on Structure Learning in healthy adults: study protocol for a randomised controlled trialChia-Lun Liu, Xiaoqin Cheng, Boon Linn Choo, et al.
Biological Psychiatry|May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disordersCameron S Carter, Deanna M Barch, Edward Bullmore, et al.
Cureus|February 3, 2025
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Cureus|January 30, 2025
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Pilot and Feasibility Studies|December 7, 2021
Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD)Eduardo Cinosi, David Adam, Ibrahim Aslan, et al.
Biological Psychiatry|June 11, 2013
Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotypeCharlotte Nymberg, Tianye Jia, Steven Lubbe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2014
Sex differences in COMT polymorphism effects on prefrontal inhibitory control in adolescenceThomas P White, Eva Loth, Katya Rubia, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Biological Psychiatry|October 4, 2002
Preclinical models: status of basic research in depressionEric J Nestler, Elizabeth Gould, Husseini Manji, et al.
Biological Psychiatry|May 10, 2008
Identifying cognitive mechanisms targeted for treatment development in schizophrenia: an overview of the first meeting of the Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia InitiativeCameron S Carter, Deanna M Barch, Robert W Buchanan, et al.
Schizophrenia Bulletin|November 22, 2008
Selecting paradigms from cognitive neuroscience for translation into use in clinical trials: proceedings of the third CNTRICS meetingDeanna M Barch, Cameron S Carter, Amy Arnsten, et al.
Trials|August 11, 2023
Potential cognitive and neural benefits of a computerised cognitive training programme based on Structure Learning in healthy adults: study protocol for a randomised controlled trialChia-Lun Liu, Xiaoqin Cheng, Boon Linn Choo, et al.
Biological Psychiatry|May 3, 2011
Cognitive Neuroscience Treatment Research to Improve Cognition in Schizophrenia II: developing imaging biomarkers to enhance treatment development for schizophrenia and related disordersCameron S Carter, Deanna M Barch, Edward Bullmore, et al.
Cureus|February 3, 2025
Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Cureus|January 30, 2025
Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'Sorcha O'Connor, Kate Godfrey, Sara Reed, et al.
Pilot and Feasibility Studies|December 7, 2021
Feasibility and acceptability of transcranial stimulation in obsessive-compulsive symptoms (FEATSOCS): study protocol for a randomised controlled trial of transcranial direct current stimulation (tDCS) in obsessive-compulsive disorder (OCD)Eduardo Cinosi, David Adam, Ibrahim Aslan, et al.
Biological Psychiatry|June 11, 2013
Neural mechanisms of attention-deficit/hyperactivity disorder symptoms are stratified by MAOA genotypeCharlotte Nymberg, Tianye Jia, Steven Lubbe, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|May 14, 2014
Sex differences in COMT polymorphism effects on prefrontal inhibitory control in adolescenceThomas P White, Eva Loth, Katya Rubia, et al.
Pageof 4